Gemcitabine (Gemzar) and irinotecan (CPT-11, Camptosar) are active cytotoxic drugs against pancreatic cancer. Preclinical data evaluating the combination of gemcitabine and irinotecan suggest dose-dependent synergistic
Chris Y. Brunson, MD
Advertisement
Articles by Chris Y. Brunson, MD
Advertisement
Latest Updated Articles
- Irinotecan/Gemcitabine Combination Chemotherapy in Pancreatic Cancer
Published: March 2nd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Managing BCMA/GPRC5D-Associated CRS and ICANS in the Real-World Setting
2
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
3
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
4
Addressing Early Talquetamab Toxicity Concerns
5
